{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T06:51:06Z","timestamp":1773557466068,"version":"3.50.1"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T00:00:00Z","timestamp":1649289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Current guidelines, rarely if at all, address decision-making for revascularization when bypass surgery is not a possibility for high-risk cases. Patients who are surgically turned down are routinely excluded from clinical trials, even though they remain symptomatic. Furthermore, the reasons for surgical ineligibility are often times not captured in standardized risk models. There is no data regarding health status outcomes following PCI procedures in these patients and the ultimate question remains whether the benefits of PCI outweigh its risks in this controversial subpopulation. When CHIP (Complex High risk Indicated Percutaneous coronary interventions) is selected for these very complex individuals, there is no unanimity regarding the goals for interventional revascularization (for instance, the ambition to achieve completeness of revascularization vs. more targeted or selective PCI). The recognition that, worldwide, these patients are becoming increasingly prevalent and increasingly commonplace in the cardiac catheterization labs, along with the momentum for more complex interventional procedures and expanding skillsets, gives us a timely opportunity to better examine the outcomes for these patients and inform clinical decision-making.<\/jats:p>","DOI":"10.3389\/fcvm.2022.872398","type":"journal-article","created":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T05:14:33Z","timestamp":1649308473000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Surgical Turned-Downed CHIP Cases\u2014Can PCI Save the Day?"],"prefix":"10.3389","volume":"9","author":[{"given":"Alexandru","family":"Achim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madalin","family":"Marc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoltan","family":"Ruzsa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","article-title":"ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"79","author":"Lawton","year":"2022","journal-title":"J Am Coll Cardiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/eurheartj\/ehy855","article-title":"ESC scientific document group. ESC\/EACTS Guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur Heart J."},{"key":"B3","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1056\/NEJMoa2112299","article-title":"FAME 3 Investigators fractional flow reserve-guided pci as compared with coronary bypass surgery","volume":"386","author":"Fearon","year":"2022","journal-title":"N Engl J Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"ezac036","DOI":"10.1093\/ejcts\/ezac036","article-title":"FAME 3 fails to defame coronary artery bypass grafting: what went wrong in the percutaneous coronary intervention arm?","volume":"29","author":"Achim","year":"2022","journal-title":"Eur J Cardiothorac Surg."},{"key":"B5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ijcard.2021.05.005","article-title":"Revascularization decisions in patients with chronic coronary syndromes: results of the second international survey on interventional strategy (ISIS-2)","volume":"336","author":"Toth","year":"2021","journal-title":"Int J Cardiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1161\/CIRCULATIONAHA.114.011541","article-title":"Surgical ineligibility and mortality among patients with unprotected left main or multivessel coronary artery disease undergoing percutaneous coronary intervention","volume":"130","author":"Waldo","year":"2014","journal-title":"Circulation."},{"key":"B7","unstructured":"American College of Cardiology2022"},{"key":"B8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jcin.2021.09.039","article-title":"Defining percutaneous coronary intervention complexity and risk: an analysis of the United Kingdom BCIS database 2006\u20132016","volume":"15","author":"Protty","year":"2022","journal-title":"JACC Cardiovasc Interv."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1161\/CIRCULATIONAHA.112.098194","article-title":"A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 vs. intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study","volume":"126","author":"O'Neill","year":"2012","journal-title":"Circulation."},{"key":"B10","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1161\/CIRCULATIONAHA.112.132209","article-title":"BCIS-1 Investigators. Long-term mortality data from the balloon pump-assisted coronary intervention study (BCIS-1): a randomized, controlled trial of elective balloon counterpulsation during high-risk percutaneous coronary intervention","volume":"127","author":"Perera","year":"2013","journal-title":"Circulation"},{"key":"B11","doi-asserted-by":"publisher","first-page":"5243913","DOI":"10.1155\/2019\/5243913","article-title":"Long-term outcomes of extent of revascularization in complex high risk and indicated patients undergoing impella-protected percutaneous coronary intervention: report from the roma-Verona Registry","volume":"2019","author":"Burzotta","year":"2019","journal-title":"J Interv Cardiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ijcard.2019.05.065","article-title":"Clinical expert consensus document on the use of percutaneous left ventricular assist support devices during complex high-risk indicated PCI: Italian Society of interventional cardiology Working Group","volume":"293","author":"Chieffo","year":"2019","journal-title":"Int J Cardiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1016\/j.jacc.2015.03.036","article-title":"SCAI\/ACC\/HFSA\/STS clinical expert consensus statement on the use of percutaneous mechanical circulatory support devices in cardiovascular care","volume":"65","author":"Rihal","year":"2015","journal-title":"J Am Coll Cardiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","article-title":"ISCHEMIA research group. initial invasive or conservative strategy for stable coronary disease","volume":"382","author":"Maron","year":"2020","journal-title":"N Engl J Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"S1050","DOI":"10.1016\/j.tcm.2021.10.011","article-title":"Clinical application of results of the ISCHEMIA trial","volume":"2021","author":"Kanoun Schnur","year":"2021","journal-title":"Trends Cardiovasc Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1161\/01.CIR.0000016640.99114.3D","article-title":"Survival after coronary revascularization in the elderly","volume":"105","author":"Graham","year":"2002","journal-title":"Circulation."},{"key":"B17","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s12928-018-0554-5","article-title":"Long-term outcomes in surgically ineligible patients managed with percutaneous coronary revascularization or medical therapy","volume":"34","author":"Danson","year":"2019","journal-title":"Cardiovasc Interv Ther."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1002\/ccd.29508","article-title":"Characteristics and outcomes of surgically ineligible patients with multivessel disease treated with percutaneous coronary intervention","volume":"98","author":"Shields","year":"2021","journal-title":"Catheter Cardiovasc Interv."},{"key":"B19","doi-asserted-by":"publisher","first-page":"34508615","DOI":"10.11152\/mu-3338","article-title":"The invasive intracoronary imaging assessment of left main coronary artery disease","volume":"11","author":"Dregoesc","year":"2021","journal-title":"Med Ultrason."},{"key":"B20","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.jcin.2012.02.013","article-title":"SYNTAX Investigators. Risk profile and 3-year outcomes from the SYNTAX percutaneous coronary intervention and coronary artery bypass grafting nested registries","volume":"5","author":"Head","year":"2012","journal-title":"JACC Cardiovasc Interv."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.jcin.2011.06.010","article-title":"Surgical candidacy and selection biases in nonemergent left main stenting: implications for observational studies","volume":"4","author":"McNulty","year":"2011","journal-title":"JACC Cardiovasc Interv."},{"key":"B22","doi-asserted-by":"publisher","first-page":"A50","DOI":"10.1136\/heartjnl-2014-306118.87","article-title":"87 outcomes of pci vs. medical therapy in a surgical turndown cohort from a single centre","volume":"100","author":"Danson","year":"2014","journal-title":"Heart"},{"key":"B23","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/ccd.26781","article-title":"Clinical outcomes of percutaneous coronary intervention in patients turned down for surgical revascularization","volume":"90","author":"Sukul","year":"2017","journal-title":"Catheter Cardiovasc Interv."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.872398\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T05:14:39Z","timestamp":1649308479000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.872398\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,7]]},"references-count":23,"alternative-id":["10.3389\/fcvm.2022.872398"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.872398","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,7]]},"article-number":"872398"}}